- Home
- MNY vs VYNE Comparison
MNY vs VYNE Comparison
Compare MNY & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- VYNE
- Stock Information
- Founded
- MNY 2014
- VYNE 2003
- Country
- MNY Singapore
- VYNE United States
- Employees
- MNY N/A
- VYNE N/A
- Industry
- MNY
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- VYNE Health Care
- Exchange
- MNY Nasdaq
- VYNE Nasdaq
- Market Cap
- MNY 43.4M
- VYNE 41.9M
- IPO Year
- MNY N/A
- VYNE 2018
- Fundamental
- Price
- MNY $1.17
- VYNE $2.92
- Analyst Decision
- MNY
- VYNE Strong Buy
- Analyst Count
- MNY 0
- VYNE 1
- Target Price
- MNY N/A
- VYNE $5.75
- AVG Volume (30 Days)
- MNY 93.7K
- VYNE 143.8K
- Earning Date
- MNY 12-04-2024
- VYNE 11-07-2024
- Dividend Yield
- MNY N/A
- VYNE N/A
- EPS Growth
- MNY N/A
- VYNE N/A
- EPS
- MNY N/A
- VYNE N/A
- Revenue
- MNY $88,967,081.00
- VYNE $493,000.00
- Revenue This Year
- MNY $26.64
- VYNE $32.31
- Revenue Next Year
- MNY $25.46
- VYNE N/A
- P/E Ratio
- MNY N/A
- VYNE N/A
- Revenue Growth
- MNY 28.08
- VYNE 39.27
- 52 Week Low
- MNY $0.76
- VYNE $1.57
- 52 Week High
- MNY $4.70
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- MNY 49.89
- VYNE 62.09
- Support Level
- MNY $1.12
- VYNE $2.86
- Resistance Level
- MNY $1.29
- VYNE $3.05
- Average True Range (ATR)
- MNY 0.09
- VYNE 0.22
- MACD
- MNY -0.00
- VYNE -0.02
- Stochastic Oscillator
- MNY 39.13
- VYNE 45.45
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.